Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Oligopeptides/administration & dosage"'
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 140 (2019) pp. 100-108
Wound healing, when compromised, may be guided by biological cues such as Arg-Gly-Asp (RGD), a peptide known to induce cell adhesion and migration, eventually combined with adapted nanocarriers. Three different formulations were prepared and investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039e0cb76a363f238219579e9d6aac79
https://pubmed.ncbi.nlm.nih.gov/31085312
https://pubmed.ncbi.nlm.nih.gov/31085312
Autor:
Denis Ouzan, Shuhei Nishiguchi, Anne-Marie Quinson, George Kukolj, Jerry O. Stern, Christophe Moreno, Joseph Scherer, M. V. Maevskaya, L. Morano, Filipe Calinas, Peter Ferenci, Masao Omata, Kosh Agarwal, Graham R. Foster, Yakov Datsenko, Jean-François Dufour, Marc Bourlière, Elmar Zehnter, Stefan Zeuzem, Javier Crespo, Miguel Garcia, Daniel M. Forton, Tarik Asselah, Marcus Schuchmann, Christoph Sarrazin
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024
BACKGROUND & AIMS The efficacy and tolerability of faldaprevir, a potent hepatitis C virus (HCV) NS3/4A protease inhibitor, plus peginterferon and ribavirin was assessed in a double-blind, placebo-controlled phase 3 study of treatment-naïve patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48feb1ddd3b1a0089ca2b28b5256ec41
Autor:
Alexia, Cusini, Pietro L, Vernazza, Sabine, Yerly, Laurent A, Decosterd, Bruno, Ledergerber, Christoph A, Fux, Janine, Rohrbach, Nicolas, Widmer, Bernhard, Hirschel, Roman, Gaudenz, Matthias, Cavassini, Thomas, Klimkait, Franziska, Zenger, Chistine, Gutmann, Milos, Opravil, Huldyrich F, Günthard, S, Yerly
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 62, No 1 (2013) pp. 28-35
Objectives: To determine HIV-1 RNA in cerebrospinal fluid (CSF) of successfully treated patients and to evaluate if combination antiretroviral treatments with higher central nervous system penetration-effectiveness (CPE) achieve better CSF viral supp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69ea5966e74f36ca5a297559404ddb2
https://pubmed.ncbi.nlm.nih.gov/24135736
https://pubmed.ncbi.nlm.nih.gov/24135736
Autor:
Christine Bernsmeier, De Gottardi Andrea, Joachim C. Mertens, Jean-François Dufour, Markus Heim, Darius Moradpour, Magdalena Filipowicz
Publikováno v:
Swiss Medical Weekly, Vol. 142 (2012) P. w13516
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. Two first-generation protease inhibitors, telaprevir and boceprevir, have recently been approved for the treatment of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6327c536cb8fba014edf47010f2efd49
https://pubmed.ncbi.nlm.nih.gov/22367957
https://pubmed.ncbi.nlm.nih.gov/22367957
Autor:
Swiss Association for the Study of the Liver, Moradpour, D., Helbling, B., Cerny, A., De Gottardi, A., Heim, MH., Majno, P., Müllhaupt, B., Negro, F., Rubbia-Brandt, L., Semela, D., Vilei, SB., Bernsmeier, C., Bihl, F., Borovicka, J., Dill, M., Dufour, JF., Filipowicz, M., Geier, A., Gerlach, T., Giostra, E., Gonvers, JJ., Goossens, N., Gubler, C., Hadengue, A., Hellstern, M., Hirschi, C., Jochum, W., Krähenbühl, S., Kullak-Ublick, G., Lange, C., Lavanchy, D., Malinverni, R., McLin, V., Mentha, G., Mertens, JC., Nasser, S., Oneta, C., Pache, I., Sauter, B., Spahr, L., Steuerwald, M., Stickel, F., Stieger, B., Wehr, K., Zala, G.
Publikováno v:
Swiss Medical Weekly, vol. 142, pp. w13516
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. Two first-generation protease inhibitors, telaprevir and boceprevir, have recently been approved for the treatment of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::6ee87f41a92e705c347129154dd61036
https://serval.unil.ch/notice/serval:BIB_24285838CE70
https://serval.unil.ch/notice/serval:BIB_24285838CE70
Autor:
Luigia, Elzi, Catia, Marzolini, Hansjakob, Furrer, Bruno, Ledergerber, Matthias, Cavassini, Bernard, Hirschel, Pietro, Vernazza, Enos, Bernasconi, Rainer, Weber, Manuel, Battegay
Publikováno v:
Archives of Internal Medicine, Vol. 170, No 1 (2010) pp. 57-65
BACKGROUND: Adverse effects of combination antiretroviral therapy (CART) commonly result in treatment modification and poor adherence. METHODS: We investigated predictors of toxicity-related treatment modification during the first year of CART in 131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0140ffb71465de431fa6502668040588
https://archive-ouverte.unige.ch/unige:7191
https://archive-ouverte.unige.ch/unige:7191
Autor:
Oliviero L. Gobbo, Christian Kerskens, Lawrence C. S. Tam, Anna-Sophia Kiang, G. Jane Farrar, Paul F. Kenna, Matthew Campbell, Anh T. H. Nguyen, Peter Humphries, Marian M. Humphries, Sorcha Ní Dhubhghaill
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 106(42)
PUBLISHED
Degenerative retinopathies, including age-related macular degeneration, diabetic retinopathy, and hereditary retinal disorders?major causes of world blindness?are potentially treatable by using low-molecular weight neuroprotective, ant
Degenerative retinopathies, including age-related macular degeneration, diabetic retinopathy, and hereditary retinal disorders?major causes of world blindness?are potentially treatable by using low-molecular weight neuroprotective, ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0639fc257cb797202143792d3980c088
https://pubmed.ncbi.nlm.nih.gov/19822744
https://pubmed.ncbi.nlm.nih.gov/19822744
Publikováno v:
Journal of Cell Science, Vol. 114, No Pt 8 (2001) pp. 1545-1553
Europe PubMed Central
Europe PubMed Central
Integrins are implicated in cell adhesion, migration and homeostasis. An important feature is their ability to adopt different affinity states that can be regulated by a variety of intra- and extracellular factors. To study affinity modulation of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c32aadfc411e0b9e9afd8675c0583d42
https://archive-ouverte.unige.ch/unige:11413
https://archive-ouverte.unige.ch/unige:11413
Publikováno v:
Nature Biotechnology, Vol. 14, No 13 (1996) pp. 1710-3
Transdermal administration by iontophoresis (enhanced transport via the skin using the driving force of an applied electric field) has been successfully demonstrated but no formal relationship between peptide sequence/structure and efficiency of deli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03e42a757442261de306a1d54cc46b63
https://pubmed.ncbi.nlm.nih.gov/9634857
https://pubmed.ncbi.nlm.nih.gov/9634857
Autor:
Jürg Nussberger, Hans R. Brunner, Tam T. Guyene, Pierre Corvol, Joël Ménard, Xavier Jeunemaitre
Publikováno v:
American journal of hypertension, vol. 2, no. 11 Pt 1, pp. 819-827
The new renin inhibitor CGP 38560A has been shown to block angiotensin (ANG) production in healthy volunteers. In order to determine its potential antihypertensive effect, the compound was administered in a 30-min infusion, in 12 hypertensive patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6b62d95aea6b7aaad8bcc942cb3a3e
https://pubmed.ncbi.nlm.nih.gov/2686709
https://pubmed.ncbi.nlm.nih.gov/2686709